Deepa P Ramasamy
Overview
Explore the profile of Deepa P Ramasamy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jakimovski D, Gibney B, Marr K, Ramasamy D, Dwyer M, Bergsland N, et al.
Eur J Neurol
. 2022 Apr;
29(8):2299-2308.
PMID: 35474598
Background And Purpose: Hypoperfusion, vascular pathology, and cardiovascular risk factors are associated with disease severity in multiple sclerosis (MS). We aimed to assess relationships between cerebral arterial blood flow (CABF)...
2.
Barnett M, Bergsland N, Weinstock-Guttman B, Butzkueven H, Kalincik T, Desmond P, et al.
Neuroimage Clin
. 2021 Sep;
32:102802.
PMID: 34469848
Background: Methodological challenges limit the use of brain atrophy and lesion burden measures in the follow-up of multiple sclerosis (MS) patients on clinical routine datasets. Objective: To determine the feasibility...
3.
Fuchs T, Dwyer M, Jakimovski D, Bergsland N, Ramasamy D, Weinstock-Guttman B, et al.
Neuroimage Clin
. 2021 Jun;
31:102705.
PMID: 34091352
Background: Although quantitative measures from research-quality MRI provide a means to study multiple sclerosis (MS) pathology in vivo, these metrics are often unavailable in legacy clinical datasets. Objective: To determine...
4.
Jakimovski D, Zivadinov R, Bergsland N, Ramasamy D, Hagemeier J, Genovese A, et al.
Neuroimage Clin
. 2021 Jan;
29:102554.
PMID: 33472143
Background: Greater brain atrophy is associated with disability progression (DP) in patients with multiple sclerosis (PwMS). However, methodological challenges limit its routine clinical use. Objective: To determine the feasibility of...
5.
Hildesheim F, Ramasamy D, Bergsland N, Jakimovski D, Dwyer M, Hojnacki D, et al.
Mult Scler Relat Disord
. 2020 Dec;
47:102653.
PMID: 33333417
Background: Leptomeningeal contrast enhancement (LMCE) has previously shown potential to be an indirect marker for leptomeningeal inflammation in multiple sclerosis (MS). Dura mater (DME), inclusive falx cerebri (FCE) enhancement and...
6.
Jakimovski D, Dujmic D, Hagemeier J, Ramasamy D, Bergsland N, Dwyer M, et al.
Mult Scler Relat Disord
. 2020 Dec;
46:102588.
PMID: 33296984
Background: Late-onset multiple sclerosis (LOMS) is associated with faster disability progression than persons with adult-onset MS (PwAOMS). The differences in brain atrophy are currently unknown. Objectives: To determine MRI-derived atrophy...
7.
Subramanian K, Utriainen D, Ramasamy D, Sethi S, Schweser F, Beaver J, et al.
Diagnostics (Basel)
. 2020 Nov;
10(11).
PMID: 33198313
We hypothesized that cerebral microbleeds (CMBs) in multiple sclerosis (MS) patients will be detected with higher prevalence compared to healthy controls (HC) and that quantitative susceptibility mapping (QSM) will help...
8.
Ziliotto N, Zivadinov R, Jakimovski D, Baroni M, Bergsland N, Ramasamy D, et al.
Front Neurol
. 2020 Nov;
11:553616.
PMID: 33178104
Several studies suggested cross talk among components of hemostasis, inflammation, and immunity pathways in the pathogenesis, neurodegeneration, and occurrence of cerebral microbleeds (CMBs) in multiple sclerosis (MS). This study aimed...
9.
Pol S, Liang S, Schweser F, Dhanraj R, Schubart A, Preda M, et al.
Exp Neurol
. 2020 Sep;
335:113488.
PMID: 32991933
Background: The human myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (huMOG-EAE) model, generates B-cell driven demyelination in mice, making it a suitable multiple sclerosis model to study B cell depletion. Objectives:...
10.
Jakimovski D, Zivadinov R, Dwyer M, Bergsland N, Ramasamy D, Browne R, et al.
J Neurol Sci
. 2020 Sep;
418:117120.
PMID: 32947088
Background: The pathophysiological mechanisms underlying the associations of multiple sclerosis (MS) neurodegeneration serum cholesterol profiles is currently unknown. Objective: To determine associations between lipid profile measures and cerebral perfusion-based indices...